Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

6.98
Delayed Data
As of May 18
 0.00 / 0.00%
Today’s Change
6.17
Today|||52-Week Range
11.93
-14.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues47.5M42.5M35.9M33.4M
 
 
 
 
 
Cost of Goods Sold4.5M3.5M4.0M6.4M
 
 
 
 
 
Depreciation And Amortization793.5K1.1M2.3M2.0M
 
 
 
 
 
 
Operating ExpensesGross Income42.2M37.8M29.6M25.0M
 
 
 
 
 
General Expenses19.7M21.0M36.9M34.5M
 
 
 
 
 
Research And Development7.0M8.7M12.7M10.0M
 
 
 
 
 
Total Operating Expenses25.0M25.7M43.2M42.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income22.5M16.8M-7.3M-9.5M
 
 
 
 
 
Extraordinary Credit13.6M11.2M1.7M--
 
 
 
 
Extraordinary Charge-1.1M0.000.00-3.1M
 
 
 
Interest Expense On Debt269.6K281.6K276.0K1.6M
 
 
 
 
 
Other Expenses2.5M1.9M-1.4M-395.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income37.2M29.6M-7.2M-14.6M
 
 
 
 
 
Income Taxes-7.6M-6.3M-2.5M-2.3M
 
 
 
 
 
Net Income29.7M23.2M-9.7M-12.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.1M40.1M39.4M38.6M
 
 
 
 
 
Shares To Calculate EPS Diluted42.5M41.3M39.4M38.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.72$0.58-$0.25-$0.32
 
 
 
 
 
EPS Diluted$0.70$0.56-$0.25-$0.32